Migdal Insurance & Financial Holdings’s BioNTech BNTX Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-605	Closed	-$65K	–	331
2025 Q2	$65K	Hold	605	–	–	﹤0.01%	250
2025 Q1	$57K	Hold	605	–	–	﹤0.01%	276
2024 Q4	$68K	Hold	605	–	–	﹤0.01%	235
2024 Q3	$72K	Hold	605	–	–	﹤0.01%	242
2024 Q2	$49K	Sell	605 -100	-14%	-$9.14K	﹤0.01%	300
2024 Q1	$65K	Hold	705	–	–	﹤0.01%	264
2023 Q4	$74K	Hold	705	–	–	﹤0.01%	305
2023 Q3	$73K	Hold	705	–	–	﹤0.01%	307
2023 Q2	$75K	Hold	705	–	–	﹤0.01%	299
2023 Q1	$87K	Hold	705	–	–	﹤0.01%	324
2022 Q4	$107K	Buy	+705	New	+$108K	﹤0.01%	254
2022 Q3	–	Sell	-705	Closed	-$100K	–	522
2022 Q2	$100K	Hold	705	–	–	﹤0.01%	306
2022 Q1	$123K	Sell	705 -615	-47%	-$103K	﹤0.01%	325
2021 Q4	$318K	Buy	+1,320	New	+$362K	﹤0.01%	265
2021 Q2	–	Sell	-5,714	Closed	-$624K	–	593
2021 Q1	$624K	Buy	5,714 +3,546	+164%	+$377K	0.01%	297
2020 Q4	$177K	Buy	+2,168	New	+$213K	﹤0.01%	331

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Migdal Insurance & Financial Holdings's BNTX Position: Q3 2025 in Review

Migdal Insurance & Financial Holdings sold out of BioNTech (BNTX) in Q3 2025, closing a stake of 605 shares — an estimated $65K sold.

Migdal Insurance & Financial Holdings first reported a position in BNTX in Q4 2020 and held it in 16 quarters. The position peaked at $624K in Q1 2021. 254 funds tracked by Wall St. Rank hold BNTX as of Q3 2025.

Migdal Insurance & Financial Holdings reported no remaining BioNTech position as of Q3 2025 after selling out during the quarter.
Migdal Insurance & Financial Holdings sold 605 BioNTech shares in Q3 2025, an estimated $65K.
Migdal Insurance & Financial Holdings first reported a position in BioNTech in Q4 2020 and held it in 16 quarters.
Migdal Insurance & Financial Holdings's BioNTech position peaked at $624K in Q1 2021.
254 funds tracked by Wall St. Rank held BioNTech as of Q3 2025.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q3 2025, filed 30 Oct 2025.